Sangamo Therapeutics
在场
高管
查看带有其 19 名主要高管的组织结构图
Sangamo Therapeutics 搜索最多的简介
- Alexander Macrae, Director, President and Chief Executive Officer
- Robert Carey, Director
- Stewart Parker, Chairman of the Board
创建提醒
跟踪 Sangamo Therapeutics 的高管变动
药店
Sangamo Therapeutics 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
Sangamo Therapeutics 的最新新闻稿
- Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast | Sangamo Therapeutics, Inc.
- European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation | Sangamo Therapeutics, Inc.
- News Releases | Sangamo Therapeutics, Inc.
- News Releases | Sangamo Therapeutics, Inc.
- Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences | Sangamo Therapeutics, Inc.
- Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results | Sangamo Therapeutics, Inc.
- Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) | Sangamo Therapeutics, Inc.
- Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast | Sangamo Therapeutics, Inc.
- News Releases | Investor Relations | Sangamo Therapeutics, Inc.
- Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment | Sangamo Therapeutics, Inc.
- View more press releases Close
通过电子邮件
